Prospect Venture Partners

Prospect Venture Partners

A venture capital and private equity firm investing in biomedical technology companies.

All edits

Edits on 3 Mar, 2020
Neelam Jhaveri
Neelam Jhaveri approved a suggestion from Golden's AI on 3 Mar, 2020
Edits made to:
Article (+7/-7 characters)
Article

According to the firms website (as of November 2019) they have raised over $1 billion in capital, led more than 50 funding rounds, and invest in seed and growth stage companies. Notable investments made by Prospect Venture Partners include: Amicus Therapeutics, Amira Pharmaceuticals, Cabochon, Complete Genomics, Gloucester Pharmaceuticals, Healtheon, Infinity Pharmaceuticals, Idun Pharmaceuticals, Intuitive Surgical, Kythera Biopharmaceuticals, SentreHeart, Rinat Neuroscience, Tinea Pharmaceuticals, TrubionTrubion, Visiogen, and Vitae Pharmaceuticals,

Edits on 21 Feb, 2020
Aime Anne Nisay
Aime Anne Nisay approved a suggestion from Golden's AI on 21 Feb, 2020
Edits made to:
Article (+20/-20 characters)
Article

On July 30, 2001 Prospect Venture Partners announced raising $500 million for their third venture capital fundventure capital fund. The fund will be used to invest in early-stage biotechnology, biopharmaceutical, and medical devices companies. Prospect Venture Partners will use the fund to make investments in approximately 30 companies ranging in size from $10 to $15 million.

Edits on 9 Feb, 2020
Aime Anne Nisay
Aime Anne Nisay approved a suggestion from Golden's AI on 9 Feb, 2020
Edits made to:
Article (+8/-8 characters)
Article

According to the firms website (as of November 2019) they have raised over $1 billion in capital, led more than 50 funding rounds, and invest in seed and growth stage companies. Notable investments made by Prospect Venture Partners include: Amicus Therapeutics, Amira Pharmaceuticals, Cabochon, Complete Genomics, Gloucester Pharmaceuticals, Healtheon, Infinity Pharmaceuticals, Idun Pharmaceuticals, Intuitive Surgical, Kythera Biopharmaceuticals, SentreHeart, Rinat Neuroscience, Tinea Pharmaceuticals, Trubion, VisiogenVisiogen, and Vitae Pharmaceuticals,

Edits on 8 Feb, 2020
Aime Anne Nisay
Aime Anne Nisay approved a suggestion from Golden's AI on 8 Feb, 2020
Edits made to:
Article (+26/-26 characters)
Article

According to the firms website (as of November 2019) they have raised over $1 billion in capital, led more than 50 funding rounds, and invest in seed and growth stage companies. Notable investments made by Prospect Venture Partners include: Amicus Therapeutics, Amira Pharmaceuticals, Cabochon, Complete Genomics, Gloucester Pharmaceuticals, Healtheon, Infinity Pharmaceuticals, Idun Pharmaceuticals, Intuitive Surgical, Kythera BiopharmaceuticalsKythera Biopharmaceuticals, SentreHeart, Rinat Neuroscience, Tinea Pharmaceuticals, Trubion, Visiogen, and Vitae Pharmaceuticals,

Aime Anne Nisay
Aime Anne Nisay approved a suggestion from Golden's AI on 8 Feb, 2020
Edits made to:
Article (+26/-26 characters)
Article

According to the firms website (as of November 2019) they have raised over $1 billion in capital, led more than 50 funding rounds, and invest in seed and growth stage companies. Notable investments made by Prospect Venture Partners include: Amicus Therapeutics, Amira Pharmaceuticals, Cabochon, Complete Genomics, Gloucester PharmaceuticalsGloucester Pharmaceuticals, Healtheon, Infinity Pharmaceuticals, Idun Pharmaceuticals, Intuitive Surgical, Kythera Biopharmaceuticals, SentreHeart, Rinat Neuroscience, Tinea Pharmaceuticals, Trubion, Visiogen, and Vitae Pharmaceuticals,

Edits on 4 Feb, 2020
Henry Ogolla
Henry Ogolla approved a suggestion from Golden's AI on 4 Feb, 2020
Edits made to:
Article (+21/-21 characters)
Article

According to the firms website (as of November 2019) they have raised over $1 billion in capital, led more than 50 funding rounds, and invest in seed and growth stage companies. Notable investments made by Prospect Venture Partners include: Amicus Therapeutics, Amira Pharmaceuticals, Cabochon, Complete Genomics, Gloucester Pharmaceuticals, Healtheon, Infinity Pharmaceuticals, Idun Pharmaceuticals, Intuitive Surgical, Kythera Biopharmaceuticals, SentreHeart, Rinat Neuroscience, Tinea Pharmaceuticals, Trubion, Visiogen, and Vitae PharmaceuticalsVitae Pharmaceuticals,

Edits on 29 Jan, 2020
Neelam Jhaveri
Neelam Jhaveri approved a suggestion from Golden's AI on 29 Jan, 2020
Edits made to:
Article (+19/-19 characters)
Article

According to the firms website (as of November 2019) they have raised over $1 billion in capital, led more than 50 funding rounds, and invest in seed and growth stage companies. Notable investments made by Prospect Venture Partners include: Amicus TherapeuticsAmicus Therapeutics, Amira Pharmaceuticals, Cabochon, Complete Genomics, Gloucester Pharmaceuticals, Healtheon, Infinity Pharmaceuticals, Idun Pharmaceuticals, Intuitive Surgical, Kythera Biopharmaceuticals, SentreHeart, Rinat Neuroscience, Tinea Pharmaceuticals, Trubion, Visiogen, and Vitae Pharmaceuticals,

Edits on 27 Jan, 2020
Neelam Jhaveri
Neelam Jhaveri approved a suggestion from Golden's AI on 27 Jan, 2020
Edits made to:
Article (+15/-15 characters)
Article

Prospect Venture Partners is a venture capitalventure capital and private equity firm investing in biomedical technology companies that is headquartered in Palo Alto, California and was founded in 1997 by Alex Barkas.

Edits on 26 Jan, 2020
Henry Ogolla
Henry Ogolla approved a suggestion from Golden's AI on 26 Jan, 2020
Edits made to:
Article (+21/-21 characters)
Article

Prospect Venture Partners is a venture capital and private equity firm investing in biomedical technology companies that is headquartered in Palo Alto, CaliforniaPalo Alto, California and was founded in 1997 by Alex Barkas.

Edits on 14 Jan, 2020
Neelam Jhaveri
Neelam Jhaveri approved a suggestion from Golden's AI on 14 Jan, 2020
Edits made to:
Article (+11/-11 characters)
Article

According to the firms website (as of November 2019) they have raised over $1 billion in capital, led more than 50 funding rounds, and invest in seed and growth stage companies. Notable investments made by Prospect Venture Partners include: Amicus Therapeutics, Amira Pharmaceuticals, Cabochon, Complete Genomics, Gloucester Pharmaceuticals, Healtheon, Infinity Pharmaceuticals, Idun Pharmaceuticals, Intuitive Surgical, Kythera Biopharmaceuticals, SentreHeartSentreHeart, Rinat Neuroscience, Tinea Pharmaceuticals, Trubion, Visiogen, and Vitae Pharmaceuticals,

Edits on 6 Jan, 2020
Charlie Hilton
Charlie Hilton approved a suggestion from Golden's AI on 6 Jan, 2020
Edits made to:
Article (+21/-21 characters)
Article

According to the firms website (as of November 2019) they have raised over $1 billion in capital, led more than 50 funding rounds, and invest in seed and growth stage companies. Notable investments made by Prospect Venture Partners include: Amicus Therapeutics, Amira PharmaceuticalsAmira Pharmaceuticals, Cabochon, Complete Genomics, Gloucester Pharmaceuticals, Healtheon, Infinity Pharmaceuticals, Idun Pharmaceuticals, Intuitive Surgical, Kythera Biopharmaceuticals, SentreHeart, Rinat Neuroscience, Tinea Pharmaceuticals, Trubion, Visiogen, and Vitae Pharmaceuticals,

Edits on 2 Dec, 2019
Jude Gomila
Jude Gomila approved a suggestion from Golden's AI on 2 Dec, 2019
Edits made to:
Article (+24/-24 characters)
Article

According to the firms website (as of November 2019) they have raised over $1 billion in capital, led more than 50 funding rounds, and invest in seed and growth stage companies. Notable investments made by Prospect Venture Partners include: Amicus Therapeutics, Amira Pharmaceuticals, Cabochon, Complete Genomics, Gloucester Pharmaceuticals, Healtheon, Infinity PharmaceuticalsInfinity Pharmaceuticals, Idun Pharmaceuticals, Intuitive Surgical, Kythera Biopharmaceuticals, SentreHeart, Rinat Neuroscience, Tinea Pharmaceuticals, Trubion, Visiogen, and Vitae Pharmaceuticals,

Edits on 15 Nov, 2019
Dawson Sewell
Dawson Sewell edited on 15 Nov, 2019
Edits made to:
Infobox (+5 properties)
Description (+88/-7 characters)
Article (+1150 characters)
Topic thumbnail

Prospect Venture Partners

Company

A venture capital and private equity firm investing in biomedical technology companies.

Article

Prospect Venture Partners is a venture capital and private equity firm investing in biomedical technology companies that is headquartered in Palo Alto, California and was founded in 1997 by Alex Barkas.

Investments

According to the firms website (as of November 2019) they have raised over $1 billion in capital, led more than 50 funding rounds, and invest in seed and growth stage companies. Notable investments made by Prospect Venture Partners include: Amicus Therapeutics, Amira Pharmaceuticals, Cabochon, Complete Genomics, Gloucester Pharmaceuticals, Healtheon, Infinity Pharmaceuticals, Idun Pharmaceuticals, Intuitive Surgical, Kythera Biopharmaceuticals, SentreHeart, Rinat Neuroscience, Tinea Pharmaceuticals, Trubion, Visiogen, and Vitae Pharmaceuticals,

Investment funds

Fund III

On July 30, 2001 Prospect Venture Partners announced raising $500 million for their third venture capital fund. The fund will be used to invest in early-stage biotechnology, biopharmaceutical, and medical devices companies. Prospect Venture Partners will use the fund to make investments in approximately 30 companies ranging in size from $10 to $15 million.

Infobox
Location
Palo Alto, California
Date incorporated
1997
Full address
525 University Avenue Suite 1350 Palo Alto, CA 94301 United States
Edits on 14 Nov, 2019
Carla Faraguna
Carla Faraguna edited on 14 Nov, 2019
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 10 Jul, 2019
Will Suter"Approved suggestion from source: http://www.prospectventures.com"
Will Suter approved a suggestion from Golden's AI on 10 Jul, 2019
Edits made to:
Infobox (+1 properties)
Infobox
Edits on 17 Apr, 2019
Golden AI
Golden AI edited on 17 Apr, 2019
Edits made to:
Description (+7 characters)
Topic thumbnail

Prospect Venture Partners

Company

Edits on 31 Mar, 2019
Edita Rexha
Edita Rexha approved a suggestion from Golden's AI on 31 Mar, 2019
Edits made to:
Infobox (+3 properties)
Topic thumbnail

Prospect Venture Partners

A venture capital and private equity firm investing in biomedical technology companies.

Infobox
Is a
Company
Edita Rexha"Initial topic creation"
Edita Rexha created this topic on 31 Mar, 2019
Edits made to:
Topic thumbnail

 Prospect Venture Partners

A venture capital and private equity firm investing in biomedical technology companies.

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.